Growth Metrics

Enovis (ENOV) Gross Margin (2010 - 2026)

Enovis (ENOV) reported Gross Margin of 62.04% for Q2 2026, up 259.0% year-over-year from 17.28% in Q2 2025, and up 2.22% on a QoQ basis from 60.69% in Q4 2025.

Enovis (ENOV) has 17 years of Gross Margin data on file, last reported at 62.04% in Q2 2026.

  • Quarterly Gross Margin rose 259.0% year-over-year to 62.04% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 60.5% (up 399.0% YoY) and the FY2025 annual result came in at 59.84%, up 382.0% from the prior year.
  • Gross Margin advanced to 62.04% in Q2 2026 per ENOV's latest filing, from 60.69% in the prior quarter.
  • Across five years, Gross Margin topped out at 62.04% in Q2 2026 and bottomed at 54.64% in Q3 2022.
  • The 5-year median for Gross Margin is 57.88% (2023), against an average of 57.66%.
  • The widest annual swing landed in 2024, when Gross Margin slumped 329 bps; it then surged 587 bps in 2025.
  • Tracing ENOV's Gross Margin over 5 years: stood at 56.7% in 2022, then increased by 2 bps to 58.1% in 2023, then dropped by 6 bps to 54.82% in 2024, then gained by 11 bps to 60.69% in 2025, then increased by 2 bps to 62.04% in 2026.
  • Per Business Quant, the three latest ENOV Gross Margin figures stand at 62.04% (Q2 2026), 60.69% (Q4 2025), and 59.92% (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 56.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 63.29%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 63.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 78.01%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.22%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 62.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 38.53%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 43.89%
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn 62.04%

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 62.04%
Dec 31, 2025 60.69%
Oct 3, 2025 59.92%
Jul 4, 2025 59.29%
Apr 4, 2025 59.45%
Dec 31, 2024 54.82%
Sep 27, 2024 56.70%
Jun 28, 2024 55.01%
Mar 29, 2024 57.70%
Dec 31, 2023 58.10%
Sep 29, 2023 58.19%
Jun 30, 2023 57.96%
Mar 31, 2023 57.88%
Dec 31, 2022 56.70%
Sep 30, 2022 56.23%
Jul 1, 2022 54.64%
Apr 1, 2022 54.84%
Dec 31, 2021 52.10%
Oct 1, 2021 54.98%
Jul 2, 2021 56.33%
Apr 2, 2021 55.06%
Dec 31, 2020 42.83%
Oct 2, 2020 42.70%
Jul 3, 2020 38.86%
Apr 3, 2020 42.65%
Dec 31, 2019 44.56%
Sep 27, 2019 43.49%
Jun 28, 2019 41.39%
Mar 29, 2019 38.16%
Dec 31, 2018 31.59%
Sep 28, 2018 32.68%
Jun 29, 2018 34.22%
Mar 30, 2018 34.61%
Dec 31, 2017 30.62%
Sep 29, 2017 31.25%
Jun 30, 2017 30.43%
Mar 31, 2017 32.69%
Dec 31, 2016 30.77%
Sep 30, 2016 31.09%
Jul 1, 2016 31.19%
Apr 1, 2016 31.56%
Dec 31, 2015 31.41%
Sep 25, 2015 30.53%
Jun 26, 2015 31.99%
Mar 27, 2015 32.32%
Dec 31, 2014 32.48%
Sep 26, 2014 32.05%
Jun 27, 2014 32.37%
Mar 28, 2014 30.89%
Dec 31, 2013 30.51%
Sep 27, 2013 31.57%
Jun 28, 2013 31.45%
Mar 29, 2013 30.69%
Dec 31, 2012 29.94%
Sep 28, 2012 30.17%
Jun 29, 2012 30.11%
Mar 30, 2012 27.27%
Dec 31, 2011 34.62%
Sep 30, 2011 35.60%
Jul 1, 2011 34.63%
Apr 1, 2011 33.59%
Dec 31, 2010 35.75%
Oct 1, 2010 35.57%
Jul 2, 2010 34.95%